In this context, the strategy of targeting BAG3 protein secreted by cancer cells seems to be promising for its effect in negatively modulating both TAMs and CAFs; it is worth noting that the amount of tumor stroma and collagen fibers is decreased in murine pancreatic cancer when treated with an anti‐BAG3 monoclonal antibody. This evidence concerns the gene BAG3 and familial pancreatic carcinoma.